Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 7 Aug 24 424B5 Prospectus supplement for primary offering
- 5 Apr 24 424B5 Prospectus supplement for primary offering
- 5 Apr 24 424B5 Prospectus supplement for primary offering
- 18 Nov 22 424B5 Prospectus supplement for primary offering
- 16 Nov 22 424B5 Prospectus supplement for primary offering
- 7 Mar 22 424B5 Prospectus supplement for primary offering
- 22 Dec 21 424B5 Prospectus supplement for primary offering
- 30 Nov 21 EFFECT Notice of effectiveness
-
24 Nov 21 S-3/A Shelf registration (amended)
- 15 Nov 21 S-3 Shelf registration
BDSX similar filings
Filing view
External links
Exhibit 23.3
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 16, 2021, with respect to the financial statements of Biodesix, Inc., incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
| /s/ KPMG LLP |
Denver, Colorado
November 24, 2021